FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2143600529> ?p ?o ?g. }

• W2143600529 endingPage "33" @default.
• W2143600529 startingPage "1929" @default.
• W2143600529 abstract "9-Amino-20(S)-camptothecin (9-AC) has demonstrated efficacy against several human cancer xenografts, including cancers of the colon, breast, lung, ovary, and stomach and malignant melanoma, and is currently undergoing Phase I clinical trials. In vitro data indicate that the addition of topoisomerase I inhibitors shortly after irradiation causes conversion of single-strand breaks to double-strand breaks, resulting in synergistic lethality to cultured log-phase or quiescent malignant cells. In our study, the efficacy of 9-AC as a potential radiosensitizing agent in vivo was assessed in C3Hf/Kam female mice bearing 7.6-8-mm MCa-4 mammary tumors implanted i.m. into the right posterior thigh. In one series of experiments to determine the dose dependence of 9-AC, mice were injected twice a week with either 0.5, 1.0, or 2.0 mg/kg 9-AC (total doses of 2, 4, and 8 mg/kg, respectively) either alone or 1 h before irradiation. In a second series of experiments, the schedule dependence of 9-AC was determined by giving a constant total dose of 4 mg/kg 9-AC once (2 mg/kg), twice (1 mg/kg every third day), or four (0.5 mg/kg every other day) times per week for 2 weeks, either alone or combined with radiation. The same radiation regimen was used in all experiments: 2-Gy fractions daily for 14 consecutive days, giving a total dose of 28 Gy to the tumor-bearing leg only. Tumor response was assessed by regrowth delay and dose modification factors (DMFs) obtained by comparing regrowth delay in the groups given 9-AC alone with those given the same dose of 9-AC and radiation. 9-AC significantly delayed tumor growth when combined with radiation, and this effect was dependent on drug dose; DMFs of 2.4 [95% confidence interval (CI), 2.0-3.1], 3.7 (95% CI, 3.1-4.6), and 3.3 (95% CI, 2.7-4.1) were obtained for groups treated with total drug doses of 2.0, 4.0, and 8.0 mg/kg 9-AC, respectively. In addition, the same total dose of 4 mg/kg 9-AC was more effective when given either twice or four times a week compared with once a week, giving DMFs of 2.8 (95% CI, 2.2-3.9), 2.6 (95% CI, 2.0-3.6), and 1.7 (95% CI, 1.3-2.4), respectively. The effect of 9-AC and radiation on normal tissue toxicity was assessed in two normal tissues, jejunum and skin, in separate groups of mice. Jejunal crypt cell survival was decreased in those mice given single doses of 9-AC ranging from 0.5-4.0 mg/kg and 12.5 Gy of total body radiation compared with those given 12.5 Gy of total body irradiation alone. The same regimen of drug and radiation did not modify acute skin reactions. These results suggest that 9-AC is an effective in vivo radiosensitizing agent when given in divided doses with fractionated irradiation. In addition, the gastrointestinal tract but not skin could be a critical target tissue for the use of 9-AC combined with radiation." @default.
• W2143600529 created "2016-06-24" @default.
• W2143600529 creator A5021101281 @default.
• W2143600529 creator A5037207438 @default.
• W2143600529 creator A5070400110 @default.
• W2143600529 creator A5083929738 @default.
• W2143600529 date "1997-05-15" @default.
• W2143600529 modified "2023-09-23" @default.
• W2143600529 title "Potentiation of murine MCa-4 carcinoma radioresponse by 9-amino-20(S)-camptothecin." @default.
• W2143600529 cites W1571233136 @default.
• W2143600529 cites W1601951514 @default.
• W2143600529 cites W1823160408 @default.
• W2143600529 cites W1903533038 @default.
• W2143600529 cites W1989367240 @default.
• W2143600529 cites W1991068605 @default.
• W2143600529 cites W1997361520 @default.
• W2143600529 cites W2010265985 @default.
• W2143600529 cites W2011909208 @default.
• W2143600529 cites W2022940390 @default.
• W2143600529 cites W2028908766 @default.
• W2143600529 cites W2043703023 @default.
• W2143600529 cites W2061510201 @default.
• W2143600529 cites W2062490826 @default.
• W2143600529 cites W2070603215 @default.
• W2143600529 cites W2096253938 @default.
• W2143600529 cites W2103012321 @default.
• W2143600529 cites W2133295671 @default.
• W2143600529 cites W2152944453 @default.
• W2143600529 cites W2171465492 @default.
• W2143600529 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9157987" @default.
• W2143600529 hasPublicationYear "1997" @default.
• W2143600529 type Work @default.
• W2143600529 sameAs 2143600529 @default.
• W2143600529 citedByCount "12" @default.
• W2143600529 crossrefType "journal-article" @default.
• W2143600529 hasAuthorship W2143600529A5021101281 @default.
• W2143600529 hasAuthorship W2143600529A5037207438 @default.
• W2143600529 hasAuthorship W2143600529A5070400110 @default.
• W2143600529 hasAuthorship W2143600529A5083929738 @default.
• W2143600529 hasConcept C126322002 @default.
• W2143600529 hasConcept C142724271 @default.
• W2143600529 hasConcept C150903083 @default.
• W2143600529 hasConcept C178790620 @default.
• W2143600529 hasConcept C185592680 @default.
• W2143600529 hasConcept C207001950 @default.
• W2143600529 hasConcept C2777658100 @default.
• W2143600529 hasConcept C2778324911 @default.
• W2143600529 hasConcept C2779422922 @default.
• W2143600529 hasConcept C2779682216 @default.
• W2143600529 hasConcept C2989005 @default.
• W2143600529 hasConcept C502942594 @default.
• W2143600529 hasConcept C509974204 @default.
• W2143600529 hasConcept C71924100 @default.
• W2143600529 hasConcept C86803240 @default.
• W2143600529 hasConceptScore W2143600529C126322002 @default.
• W2143600529 hasConceptScore W2143600529C142724271 @default.
• W2143600529 hasConceptScore W2143600529C150903083 @default.
• W2143600529 hasConceptScore W2143600529C178790620 @default.
• W2143600529 hasConceptScore W2143600529C185592680 @default.
• W2143600529 hasConceptScore W2143600529C207001950 @default.
• W2143600529 hasConceptScore W2143600529C2777658100 @default.
• W2143600529 hasConceptScore W2143600529C2778324911 @default.
• W2143600529 hasConceptScore W2143600529C2779422922 @default.
• W2143600529 hasConceptScore W2143600529C2779682216 @default.
• W2143600529 hasConceptScore W2143600529C2989005 @default.
• W2143600529 hasConceptScore W2143600529C502942594 @default.
• W2143600529 hasConceptScore W2143600529C509974204 @default.
• W2143600529 hasConceptScore W2143600529C71924100 @default.
• W2143600529 hasConceptScore W2143600529C86803240 @default.
• W2143600529 hasIssue "10" @default.
• W2143600529 hasLocation W21436005291 @default.
• W2143600529 hasOpenAccess W2143600529 @default.
• W2143600529 hasPrimaryLocation W21436005291 @default.
• W2143600529 hasRelatedWork W1968969912 @default.
• W2143600529 hasRelatedWork W1988985169 @default.
• W2143600529 hasRelatedWork W1996756133 @default.
• W2143600529 hasRelatedWork W2030718289 @default.
• W2143600529 hasRelatedWork W2051593599 @default.
• W2143600529 hasRelatedWork W2418314844 @default.
• W2143600529 hasRelatedWork W2423535787 @default.
• W2143600529 hasRelatedWork W2992703031 @default.
• W2143600529 hasRelatedWork W3031995320 @default.
• W2143600529 hasRelatedWork W2096575650 @default.
• W2143600529 hasVolume "57" @default.
• W2143600529 isParatext "false" @default.
• W2143600529 isRetracted "false" @default.
• W2143600529 magId "2143600529" @default.
• W2143600529 workType "article" @default.